OPEN Health acquires New York's Acsel Health

KUALA LUMPUR, Feb 14 (Bernama) -- OPEN Health, a global provider of scientific communications and Health Economics and Outcomes Research (HEOR) & market access services, announced the acquisition of Acsel Health (Acsel), a New York-based life science strategy and advisory firm.

OPEN Health Chief Executive Officer, Rob Barker said Acsel’s expert team and long-standing client relationships significantly strengthened the company’s ability to support the commercialisation of its clients’ assets and unlock access for patients.

“We are excited to welcome Acsel Health into the OPEN Health Group and look forward to working with our new colleagues to offer our clients innovative, scientific solutions around the globe,” he said in a statement.

Meanwhile, Acsel Health Managing Partner, Lujing Wang said: “We are thrilled to join OPEN Health and to work with a wider team to solve for today’s demands and meet tomorrow’s expectations for pharma and biotech customers.”

“With new colleagues and capabilities to partner with, we are equipped to answer the most challenging cross-disciplinary questions in life science across all key therapeutic areas,” added Wang.

Acsel’s deep industry expertise, scientific rigour and actionable analysis drives its success in providing valued partnership to life science companies, hence these capabilities will complement OPEN Health’s existing offering, broadening the range of services it offers to pharma and biotech companies.

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient wellbeing.

-- BERNAMA